The Future of Value-Based Care
A new ten-year experiment called ACCESS is about to test exactly that question — and it could reshape how chronic illness is cared for in America.
By the team at Healthmonix · Reading time ~5 min
Two ways to pay for care. One rewards activity that goes nowhere; the other rewards the patient actually getting better — the bet at the heart of the ACCESS model.Imagine you have high blood pressure. Today, Medicare pays your care team for the things they do — the office visit, the device, the check-in. Each action has a billing code, and the system rewards activity. What it doesn't pay for, directly, is the thing you actually care about: your blood pressure coming down, and staying down.
That gap — between paying for activity and paying for outcomes — is one of the oldest frustrations in American healthcare. Starting this July, the federal government is running a serious, decade-long experiment to close it.
It's called the ACCESS model — Advancing Chronic Care with Effective, Scalable Solutions — and it comes from Medicare's innovation arm. The premise is simple to say and genuinely hard to do: pay for whether the patient got better, not for how many times someone touched them.
“Did the patient improve from where they started?” Under ACCESS, that single question determines whether an organization gets paid.
1How it actually works
An organization enrolls a patient and records a starting point — say, a blood pressure reading, an A1c for diabetes, or a validated score for depression or anxiety. Then it delivers care however it thinks works best: an app, a connected device, a coach, a clinician, medication support, or some combination. Medicare pays a steady monthly amount along the way.
At the end of about a year, the organization reports back. Did the patient hit a meaningful improvement or reach a healthy target? If enough patients did, the organization earns its full payment. If they didn't, it earns less. The freedom to choose how to deliver care is the reward; accountability for the result is the price.
The four starting tracks
Together, those 4 tracks touch conditions that affect more than two-thirds of people on Medicare. This isn't a niche pilot for a rare disease. It targets the everyday chronic conditions that make up the bulk of the country's health spending — and the bulk of its daily suffering.
2Why this one is different
Healthcare is full of pilot programs, so it's fair to ask what makes this one worth watching. A few things stand out.
First, it invites new kinds of players to the table. Alongside traditional medical practices, the first group of participants includes connected-device makers, virtual-care companies, and technology-driven startups — many of which have never served traditional Medicare before. If you pay for outcomes and get out of the way on methods, innovation follows.
Second, it takes coordination seriously instead of assuming it. An organization managing someone's depression can't operate in a vacuum; it has to keep their regular doctor in the loop, sharing updates at the moments that matter. The model is designed so that new, tech-enabled care complements the primary care relationship rather than fragmenting it.
Third, it's built for informed choice. Medicare plans to publish a public directory of participating organizations and their results, adjusted for how sick their patients were. In a field where it's notoriously hard to know who's actually good, that kind of transparency — pick your partner based on real outcomes — is quietly radical.
3What it could mean
If ACCESS works — and that's a real if, because the hardest questions, like exactly how much Medicare will pay, are still being settled — it points toward a version of healthcare that more of us already wish we had. One where a person with diabetes or anxiety can reach for modern, technology-supported help and have it actually paid for. One where the people delivering that care are rewarded for making someone measurably better. One where "value" isn't a slogan but a number on a chart, trending in the right direction.
There are honest open questions. Will enough patients enroll? Will paying for outcomes accidentally create new problems to watch for? Will the data flow cleanly between everyone involved? These are the questions that determine whether a bold idea becomes a lasting one — and they're worth paying attention to over the next few years.
The shift from paying for activity to paying for outcomes is the direction healthcare has been promising for a decade. ACCESS is one of the most concrete steps yet.
For everyone who has ever wished the health system measured what truly matters — whether people get better — ACCESS is a genuinely hopeful experiment. It won't be perfect. But it's pointed at the right question.
Why we're watching closely
At Healthmonix, we've spent years helping clinicians and care organizations turn complex quality and cost data into clear decisions under Medicare's value-based programs. ACCESS sits right at the heart of what we care about: measuring outcomes that matter, sharing data so care teams can coordinate, and helping good ideas actually scale. We're paying close attention — and we're excited to help the organizations doing this work prove that better care, measured honestly, is possible.
— The Healthmonix Team
This article is a general, plain-language overview of a federal care model and is for informational purposes only. Program details continue to evolve; for the most current and authoritative information, consult official CMS resources.
